Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
4.490
-0.860 (-16.07%)
At close: Nov 22, 2024, 4:00 PM
4.600
+0.110 (2.45%)
After-hours: Nov 22, 2024, 7:25 PM EST
Evotec SE Employees
Evotec SE had 5,061 employees as of December 31, 2023. The number of employees increased by 109 or 2.20% compared to the previous year.
Employees
5,061
Change (1Y)
109
Growth (1Y)
2.20%
Revenue / Employee
$171,244
Profits / Employee
-$37,766
Market Cap
1.57B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
National HealthCare | 13,123 |
Patterson Companies | 7,600 |
Teladoc Health | 5,600 |
NovoCure | 1,453 |
Beam Therapeutics | 436 |
MannKind | 414 |
RxSight | 374 |
Harmony Biosciences Holdings | 246 |
EVO News
- 17 hours ago - Comment on Withdrawn Non-Binding Offer - Accesswire
- 20 hours ago - Halozyme withdraws $2.1 bln buyout offer for Evotec - Reuters
- 20 hours ago - Halozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in Discussions - PRNewsWire
- 4 days ago - Halozyme Provides Update on Non-Binding Proposal to Combine with Evotec - PRNewsWire
- 7 days ago - Large Pharma Partner Halozyme Therapeutics Offers To Acquire Germany-Based Evotec For ~$2 Billion - Benzinga
- 8 days ago - Comment on Media Report - Accesswire
- 8 days ago - Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction - PRNewsWire
- 8 days ago - Halozyme weighing buyout of drugmaker Evotec, Bloomberg News reports - Reuters